Dr. Shore on germline and somatic testing in prostate cancer
December 7th 2023"Then [we] also started looking at somatic testing, because if you only stop at germline testing, you miss another 50% of patients who would have somatic alterations who have resistant prostate cancer," says Neal D. Shore, MD, FACS.
Dr. Huelster on the use of ctDNA in upper tract urothelial carcinoma
December 4th 2023“[Although] not yet ready for prime time, ctDNA is being investigated as a very promising non-invasive plasma biomarker of invasive or advanced-stage upper tract urothelial carcinoma,” says Heather L. Huelster, MD.
Dr. Woldu on disparities in advanced renal cell carcinoma
December 1st 2023"In the study, when taking into account other factors, such as the socioeconomic factors that are available to us in the NCDB, we find that African American and Hispanic patients are about 20% less likely to receive immune checkpoint inhibition for advanced RCC," says Solomon L. Woldu, MD.
AI tool predicts survival in patients undergoing RP in the PLCO trial
November 29th 2023"Specifically when we stratified by tertiles, we saw that at 15 years there was a significant difference in cancer-specific survival for those who had a high MMAI score vs lower MMAI scores," says Eric Li, MD.
Trends in care for restoring erectile function after prostatectomy
November 23rd 2023"In general, I think there's a tremendous amount of variability in terms of how sexual medicine specialists treat patients who have had intimacy issues relating to robotic prostatectomy," says Stanton Honig, MD.
Dr. Pearlman on the safety of hyaluronic acid fillers for penile augmentation
November 21st 2023"What we found is, in a retrospective review of nearly 500 patients over a 3-year span, none of those patients reported erectile dysfunction, none of them reported loss of penile sensation, and none of them required a trip to the operating room for intervention," says Amy Pearlman, MD.
Dr. Khera highlights TRAVERSE trial of testosterone replacement therapy
November 20th 2023"So far, we have only 2 published, which is the cardiovascular results, which showed no increase in cardiovascular events, and the sexual function results, showing improvements in libido, but not erectile function, in up to 2 years," says Mohit Khera, MD, MBA, MPH.
Expert discusses the benefits of IPP in improving health care utilization
November 18th 2023“One of our early findings showed that males who have IPPs use less depression medication, have less emergency room visits, and have less clinic visits for psychiatry-related conditions,” says Roei Golan.